Liquid Biopsy Market, By Biomarker Type, By Sample Type, By Disease Indication, By End User, By Geography

Description

Liquid Biopsy Market is estimated to be valued at USD 1,354.0 Mn in 2026 and is expected to reach USD 7,340.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 27.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,354.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	27.50%	2033 Value Projection:	USD 7,340.0 Mn

Liquid biopsy is an advanced non-invasive cancer diagnostic technique that uses bio-fluids such as blood, cerebrospinal fluid (CSF), plasma, and urine for detecting cancer. Liquid biopsy uses circulating nucleic acids, circulating tumor cells (CTC), and exosomes as biomarkers for diagnosis of cancer. Increasing demand for non-invasive diagnostic procedures is expected to boost growth of the global liquid biopsy market over the forecast period. Furthermore, increasing prevalence of cancer is a major factor propelling growth of the global liquid biopsy market over the forecast period.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global Liquid Biopsy based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Biocept, Inc., Qiagen N.V., Trovagene, Inc., Janssen Global Services, LLC, MDxHealth SA, Natera, Inc., F. Hoffmann-La Roche Ltd., Silicon Biosystems, Pathway Genomics Corporation, and Sysmex Corporation.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global Liquid Biopsy report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

By Biomarker Type
- CTC (Circulating Tumor Cells)
- ctNA (Circulating Tumor Nucliec Acids)
- Exosomes
By Device Type
- Blood
- Urine
- Others
By Disease Indication
- Lung Cancer
- Prostate Cancer
- Gastrointestinal Cancer
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Others
By End User
- Hospitals
- Cancer Institutes
- Academic Institutes
- Diagnostic Centers
Global Liquid Biopsy Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- Biocept, Inc.
- Qiagen N.V.
- Trovagene, Inc.
- Janssen Global Services
- LLC, MDxHealth SA, Natera, Inc.
- F. Hoffmann-La Roche Ltd.
- Silicon Biosystems
- Pathway Genomics Corporation
- Sysmex Corporation

Product Code: CMI1223

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Biomarker Type
- Market Snippet, By Sample Type
- Market Snippet, By Disease Indication
- Market Snippet, By End User
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Technological Advancement
Regulatory Scenario

4. Global Liquid Biopsy Market, By Biomarker Type, 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
CTC (Circulating Tumor Cells)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
ctNA (Circulating Tumor Nucliec Acids)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Exosomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Liquid Biopsy Market, By Sample Type, 2021 - 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Liquid Biopsy Market, By Disease Indication 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Lung Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Gastrointestinal Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Prostate Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Breast Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Colorectal Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Leukemia
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Others
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

7. Global Liquid Biopsy Market, By End User 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Cancer Institutes
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Academic Institutes
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Diagnostic Centers
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

8. Global Liquid Biopsy Market, By Region, 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
North America
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of APAC
Middle East
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - South Africa
  - Central Africa
  - North Africa

9. Competitive Landscape

Company Profiles
- Biocept, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Qiagen N.V
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Trovagene, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Janssen Global Services, LLC
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- MDxHealth SA
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Natera, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- F. Hoffmann-La Roche Ltd
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Silicon Biosystems
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pathway Genomics Corporation
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sysmex Corporation
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies

10. Section

References
Research Methodology
About us and Sales Contact